Pulmonary fibrosis following multiple treatment with bleomycin (NSC-125066) in dogs.
D000469:Alkaline Phosphatase / Q000097:blood; D000758:Anesthesia; D000818:Animals; D001463:Barbiturates; D001761:Bleomycin / Q000009:adverse effects* / Q000633:toxicity; D001806:Blood Urea Nitrogen; D001835:Body Weight; D002712:Chlorides / Q000097:blood; D004285:Dogs; D005260:Female; D008168:Lung / Q000473:pathology; D008170:Lung Compliance / Q000187:drug effects; D008231:Lymphopenia / Q000139:chemically induced; D008297:Male; D010994:Pleura / Q000473:pathology; D011188:Potassium / Q000097:blood; D011312:Pressure; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D011859:Radiography; D012867:Skin / Q000473:pathology; D013448:Sulfobromophthalein; D013997:Time Factors; D014511:Uremia / Q000139:chemically induced
D001463:Barbiturates; D002712:Chlorides; D013448:Sulfobromophthalein; D001761:Bleomycin; D000469:Alkaline Phosphatase; D011188:Potassium